CI

At a glance

ClinicalIndex Comparison Record
N/ACompleted· 12 enrolled
Drug / intervention
Erchonia MLS + Erchonia THLdevice
Likely dose
Not stated in record
Structured eligibility isn't available for this trial yet — see the full criteria in the Eligibility tab below.

Standardized by ClinicalIndex from the ClinicalTrials.gov record · verify against the source.

Search/NCT01276535
NCT01276535N/ACompleted
CompareCT.gov

A Pilot Study to Evaluate the Efficacy of Low-level Laser Therapy in Reducing Blemishes by Quantifying a Decrease in Signs of Blemishes, Both Non-inflammatory and Inflammatory

Erchonia Corporation·interventional·Posted Jan 13, 2011·Updated Dec 11, 2015

In Brief

A clinical study evaluating Erchonia MLS + Erchonia THL for Acne. Completed, enrolled 12 participants across 1 site.

Detailed Summary

The purpose of this study is to determine whether low level laser light therapy is effective in the treatment of acne blemishes.

Study Details

Study Typeinterventional
Allocation--
Masking--
Primary Purpose--
ConditionsAcne
CountriesUnited States
Collaborators--

Timeline

N/ACompletedFinished
20102011201220132014201520162017201820192020202120222023202420252026
First PostedJan 13, 2011
Enrollment StartMar 1, 2010
Primary CompletionJun 1, 2010
TodayJul 2, 2026
Enrollment to primary: 3 monthsPosted 15.5 years ago

Interventions

Erchonia MLS + Erchonia THLdevice

The Erchonia® MLS is administered weekly for 6 continuous weeks at the test site by the study investigator. The Erchonia THL is administered twice daily for 6 continuous weeks (42 days) at home by the subject. Administration of the MLS and the THL occur simultaneously over the 6-week administration phase. The intent is to evaluate the effectiveness of Erchonia MLS \& Erchonia THL when administered together, and not to compare Erchonia MLS vs. Erchonia THL